Amryt Research Limited   Report issue

Founded: Dublin Ireland (2012)
Status: Acquired by Chiesi (2023)

Organization Overview

First Clinical Trial
2017
NCT03068780
First Marketed Drug
2012
lomitapide (juxtapid)
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

AMRYT | Amryt Pharma | Amryt Pharmaceuticals DAC